Connection

MARIE-CLAUDE GINGRAS to In Situ Nick-End Labeling

This is a "connection" page, showing publications MARIE-CLAUDE GINGRAS has written about In Situ Nick-End Labeling.
  1. PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform. PLoS One. 2012; 7(8):e40452.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.